INCLUSION CRITERIA

   - Be scheduled for cancer treatment with chemotherapy or biologics (prior chemotherapy
   and/or diagnosis of metastatic breast are allowed)

   - Have at least 6 weeks of treatment remaining

   - ≥ 21 years old

   - Able to understand written and spoken English

   - Able to swallow medication (until amendment omitting armodafinil treatment)

   - Score of 3+ on the Sleep Disruption Evaluation form, OR a score of 8+ on Insomnia
   Severity Index (ISI)

EXCLUSION CRITERIA

   - Prior treatment with armodafinil or modafinil (until amendment omitting armodafinil
   treatment)

   - Prior treatment with psycho-stimulant medication within the past 28 days (until
   amendment omitting armodafinil treatment)

   - Prior treatment with antiseizure medications (until amendment omitting armodafinil
   treatment)

   - Has continuously taken sleep medication daily for the last 28 days (until amendment
   omitting armodafinil treatment)

   - History (self-reported) of unstable medical or psychiatric illness (within the last 5
   years)

   - History of uncontrolled, cardiac disease, hypertension, severe headaches, glaucoma, or
   seizures (until amendment omitting armodafinil treatment)

   - Pregnant or nursing

   - History of substance abuse or meet criteria for current alcohol abuse or dependence

   - History (self-reported) of chronic, preexisting insomnia, sleep apnea, or restless leg
   syndrome (RLS)

   - Severe hepatic impairment (until amendment omitting armodafinil treatment)